US issues rules for removing antibiotics from farms (Update)

by Kerry Sheridan

In response to concerns about the rise in drug-resistant superbugs worldwide, US regulators Wednesday issued voluntary guidelines to help cut back on antibiotics routinely fed to farm animals.

The plan described by the Food and Drug Administration is not mandatory, and applies only to certain pharmaceuticals that are given to healthy livestock in a bid to grow bigger animals and boost food production.

"We need to be selective about the drugs we use in animals and when we use them," said William Flynn, deputy director for science policy at the FDA's Center for Veterinary Medicine.

"Antimicrobial resistance may not be completely preventable, but we need to do what we can to slow it down."

The FDA guidelines set out a three-year timeframe for phasing out the use of antibiotics that are important in human medicine for growth uses in farm animals.

Companies that make animal feed containing antibiotics would be restricted to marketing them only for sick animals.

The medicines would also have to be administered or prescribed by a veterinarian with a view to preventing or controlling disease.

The World Health Organization says inappropriate use of antimicrobial medicines in farm animals is one the factors underlying the spread of drug-resistant infections in people, including tuberculosis, malaria and gonorrhea.

Other factors include people's failure to complete the full doses of antibiotics when sick and the lack of a coordinated global response to dangerous illnesses.

Consumer advocates say 80 percent of antibiotics sold in the United States are destined for use in livestock, so leaving the responsibility in the hands of business is a mistake.

Louise Slaughter, the only microbiologist in Congress, described the FDA's voluntary guidance as "an inadequate response to the overuse of antibiotics on the farm with no mechanism for enforcement and no metric for success."

This guidance "falls woefully short of what is needed to address a public health crisis," she added in a statement.

The Center for Science in the Public Interest said there are "several loopholes" in the FDA plan that could undermine its aim.

"Unfortunately it requires the drug companies who profit from sales of their drugs to initiate the process," said CSPI food safety director Caroline Smith DeWaal.

"The good news is that the agency has pledged to evaluate levels of compliance and inform the public after 90 days if the drug industry is cooperating with the relabeling effort."

Industry representatives, including the Animal Health Institute, said they would comply with the FDA plan.

"We strongly support responsible use of antibiotic medicines and the involvement of a veterinarian whenever antibiotics are administered to food producing animals," the AHI said in a statement.

"Animal health companies have supported this policy since it was announced in 2012 and will continue to work with FDA on its implementation."

add to favorites email to friend print save as pdf

Related Stories

FDA wants limits on antibiotics given to animals

Apr 11, 2012

(AP) -- The Food and Drug Administration called on drug companies Wednesday to help limit the use of antibiotics given to farm animals, a decades-old practice that scientists say has contributed to a surge in dangerous, ...

FDA enlists companies to head off drug shortages

Oct 31, 2013

The Food and Drug Administration is announcing a new proposal designed to head off more shortages of crucial medications that have disrupted care at hospitals and health clinics nationwide.

Groups sue US over antibiotics in farm feed

May 25, 2011

A coalition of consumer groups filed a federal lawsuit Wednesday against the US Food and Drug Administration over the use of human antibiotics in animal feed, saying it creates dangerous superbugs.

FDA limits some antibiotics in livestock

Jan 04, 2012

(AP) -- The Food and Drug Administration on Wednesday ordered farmers to limit the use of a type of antibiotics they give livestock because it could make people more resistant to a key antibiotic that can save lives, encouraging ...

Recommended for you

Boxed warnings are common in novel therapeutics

Aug 19, 2014

(HealthDay)—Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.

AstraZeneca says DOJ closes probe into drug trial

Aug 19, 2014

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

Perampanel for epilepsy: Still no proof of added benefit

Aug 19, 2014

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...

User comments